Sopel R, Mincewicz G, Lewandowski D
Zakładu Alergologii PSK Nr 1 w Gdańsku.
Pneumonol Alergol Pol. 1995;63(3-4):181-4.
The study was carried out on a group of 20 patients ages 10-44. Syntaris was administered twice daily in a total dose of 100 mcg. Rhinitis symptoms were assessed by subjective scoring (graded 0-3) and by objective measurement of nasal airflow using anterior rhinomanometry. Syntaris proved to be a safe and effective drug particularly in improving nasal patency.
该研究针对一组年龄在10至44岁的20名患者进行。西他利嗪每日给药两次，总剂量为100微克。通过主观评分（0至3级）和使用前鼻测压法客观测量鼻气流来评估鼻炎症状。西他利嗪被证明是一种安全有效的药物，尤其在改善鼻腔通畅方面。
